---
document_datetime: 2025-11-13 15:25:08
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/hyrimoz-epar-all-authorised-presentations_en.pdf
document_name: hyrimoz-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.8773546
conversion_datetime: 2025-12-22 14:05:19.60871
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form    | Route of administratio n   | Immediate Packaging                                         | Content (concentration)   | Pack size                                                                  |
|------------------|-------------------|------------|------------------------|----------------------------|-------------------------------------------------------------|---------------------------|----------------------------------------------------------------------------|
| EU/1/18/1286/001 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                                  | 0.8 ml (40 mg/0.8ml)      | 1 pre-filled syringe with needle safety                                    |
| EU/1/18/1286/002 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                                  | 0.8 ml (40 mg/0.8ml)      | device 2 pre-filled syringes with needle safety                            |
| EU/1/18/1286/003 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                                  | 0.8 ml (40 mg/0.8ml)      | device 6 (3 x 2) pre-filled syringes with needle safety device (multipack) |
| EU/1/18/1286/004 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass) in pen                           | 0.8 ml (40 mg/0.8ml)      | 1 pre-filled pen                                                           |
| EU/1/18/1286/005 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | (SensoReady) pre-filled syringe (glass) in pen (SensoReady) | 0.8 ml (40 mg/0.8ml)      | 2 pre-filled pens                                                          |
| EU/1/18/1286/006 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass) in pen (SensoReady)              | 0.8 ml (40 mg/0.8ml)      | 6 (3 x 2) pre-filled pens (multipack)                                      |
| EU/1/18/1286/007 | Hyrimoz           | 20 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                                  | 0.4 ml (20 mg/0.4ml)      | 2 pre-filled syringes with needle safety device                            |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form    | Route of administratio n   | Immediate Packaging                            | Content (concentration)   | Pack size                                                           |
|------------------|-------------------|------------|------------------------|----------------------------|------------------------------------------------|---------------------------|---------------------------------------------------------------------|
| EU/1/18/1286/008 | Hyrimoz           | 80 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                     | 0.8 ml (80 mg/0.8ml)      | 1 pre-filled syringe with needle safety                             |
| EU/1/18/1286/009 | Hyrimoz           | 80 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                     | 0.8 ml (80 mg/0.8ml)      | device 2 pre-filled syringes with needle safety device              |
| EU/1/18/1286/010 | Hyrimoz           | 80 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass) in pen              | 0.8 ml (80 mg/0.8ml)      | 1 pre-filled pen                                                    |
| EU/1/18/1286/011 | Hyrimoz           | 80 mg      | Solution for injection | Subcutaneous use           | (SensoReady) pre-filled syringe (glass) in pen | 0.8 ml (80 mg/0.8ml)      | 2 pre-filled pens                                                   |
| EU/1/18/1286/012 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | (SensoReady) pre-filled syringe (glass)        | 0.4ml (40 mg/0.4ml)       | 1 pre-filled syringe with needle safety device                      |
| EU/1/18/1286/013 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                     | 0.4ml (40 mg/0.4ml)       | 2 pre-filled syringes with needle safety device                     |
| EU/1/18/1286/014 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use           | pre-filled syringe (glass)                     | 0.4ml (40 mg/0.4ml)       | 6 (3 x 2) pre-filled syringes with needle safety device (multipack) |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form    | Route of administratio   | Immediate Packaging                                         | Content (concentration)   | Pack size                         |
|------------------|-------------------|------------|------------------------|--------------------------|-------------------------------------------------------------|---------------------------|-----------------------------------|
| EU/1/18/1286/015 | Hyrimoz           | 40 mg      | Solution for injection | n Subcutaneous use       | pre-filled syringe (glass) in pen                           | 0.4ml (40 mg/0.4ml)       | 1 pre-filled pen                  |
| EU/1/18/1286/016 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use         | (SensoReady) pre-filled syringe (glass) in pen (SensoReady) | 0.4ml (40 mg/0.4ml)       | 2 pre-filled pens                 |
| EU/1/18/1286/017 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use         | pre-filled syringe (glass) in pen (SensoReady)              | 0.4ml (40 mg/0.4ml)       | 4 pre-filled pens                 |
| EU/1/18/1286/018 | Hyrimoz           | 40 mg      | Solution for injection | Subcutaneous use         | pre-filled syringe (glass) in pen                           | 0.4ml (40 mg/0.4ml)       | 6 (3 x 2) pre-filled pens         |
| EU/1/18/1286/019 | Hyrimoz           | 20 mg      | Solution for injection | Subcutaneous use         | (SensoReady) pre-filled syringe (glass)                     | 0.2ml (20 mg/0.2ml)       | (multipack) 2 pre-filled syringes |
| EU/1/18/1286/020 | Hyrimoz           | 80 mg      | Solution for injection | Subcutaneous use         | pre-filled syringe (glass) in pen (SensoReady)              | 0.8ml (80 mg/0.8ml)       | 3 pre-filled pens                 |